{"organizations": [], "uuid": "64c5790869dadc4c673a3b9cc07efa7f79e1322e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-fda-continues-to-recommend-magella/brief-fda-continues-to-recommend-magellan-lead-tests-not-be-used-with-samples-taken-from-vein-idUSFWN1R40ZM", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Continues To Recommend Magellan Lead Tests Not Be Used With Samples Taken From Vein", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T21:26:00.000+02:00", "replies_count": 0, "uuid": "64c5790869dadc4c673a3b9cc07efa7f79e1322e"}, "author": "", "url": "https://www.reuters.com/article/brief-fda-continues-to-recommend-magella/brief-fda-continues-to-recommend-magellan-lead-tests-not-be-used-with-samples-taken-from-vein-idUSFWN1R40ZM", "ord_in_thread": 0, "title": "BRIEF-FDA Continues To Recommend Magellan Lead Tests Not Be Used With Samples Taken From Vein", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "none"}, {"name": "magellan", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 22, 2018 / 7:28 PM / in 37 minutes BRIEF-FDA Continues To Recommend Magellan Lead Tests Not Be Used With Samples Taken From Vein Reuters Staff March 22 (Reuters) - U.S. FDA : * U.S FDA PROVIDES STATEMENT ON FINDINGS FROM ONGOING INVESTIGATION INTO LEAD TESTING ISSUES * U.S. FDA-CONCLUDED THAT STUDIES PERFORMED BY BD WERE ROBUST & SHOWED THERE WAS SIGNIFICANT CHANCE OF FALSE RESULTS WITH MAGELLAN’S LEADCARE TESTS ‍​ * U.S FDA SAYS CONTINUES TO RECOMMEND THAT MAGELLAN LEAD TESTS NOT BE USED WITH BLOOD SAMPLES TAKEN FROM THE VEIN * U.S FDA SAYS MAGELLAN’S LEAD TEST SYSTEMS CAN CONTINUE TO BE USED WITH BLOOD SAMPLES FROM A FINGER OR HEEL STICK * AT FDA'S REQUEST, BD IS CONDUCTING TESTING TO DETERMINE IF LAB TESTS OTHER THAN MAGELLAN LEAD TESTS ARE AFFECTED BY THIURAM INTERFERENCE​‍​ Source text: ( bit.ly/2G1K6io ) Further company coverage:", "external_links": [], "published": "2018-03-22T21:26:00.000+02:00", "crawled": "2018-03-22T22:12:54.023+02:00", "highlightTitle": ""}